label int64 1 1 | id stringlengths 10 12 | original_id stringlengths 8 9 | text stringlengths 347 29.5k |
|---|---|---|---|
1 | 79381905_0 | 79381905 | Form 10-K
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 10-K
(Mark One)
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
or
¨
TRANSITION REPOR... |
1 | 79381905_1 | 79381905 |
(I.R.S. Employer Identification No.)
520 Lake Cook Road, Suite 520
Deerfield, Illinois
60015
(Address of principal executive offices)
(zip code)
(224) 383-3000 (Registrant<U+0092>s telephone number, including area code) Securities
registered pursuant to Section 12(b) of the Act:
Tit... |
1 | 79381905_2 | 79381905 | to Section 13 or Section 15(d) of the Act. Yes ¨ No x.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file... |
1 | 79381905_3 | 79381905 | knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company.
... |
1 | 79381905_b0 | 79381905 | on March 8, 2012.
(6)
Incorporated by reference to Horizon Pharma, Inc.<U+0092>s Annual Report on Form 10-K, filed on March 23, 2012.
(7)
Incorporated by reference to Horizon Pharma, Inc.<U+0092>s Quarterly Report on Form 10-Q, filed on August 10, 2012.
(8)
Incorporated by reference to Horizon Pharma, Inc.<U+... |
1 | 79381905_b1 | 79381905 | plan.
*
Confidential treatment has been granted with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange
Commission.
(1)
Incorporated by reference to Horizon Pharma, Inc.<U+0092>s Registration Statement on Form S-1 (No. 333-168504), as amende... |
1 | 79383915_0 | 79383915 | Form 20-F
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION WASHINGTON, D.C. 20549
FORM 20-F (Mark One)
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES... |
1 | 79383915_1 | 79383915 | 32846
CRH public limited company (Exact name of
Registrant as specified in its charter)
Republic of Ireland (Jurisdiction of
incorporation or organisation)
Belgard Castle, Clondalkin, Dublin 22, Ireland
(Address of principal executive offices)
Maeve Carton
Tel: +353 1 404 1000 Fax: +353... |
1 | 79383915_2 | 79383915 | 80>0.34 each**
The New York Stock Exchange*
American Depositary Shares, each representing the right to receive
The New York Stock Exchange
one Ordinary Share
CRH America Inc.
4.125% Notes due 2016 guaranteed by CRH plc
The New York Stock Exchange
6.000% Notes due 2016 guaranteed by CR... |
1 | 79383915_3 | 79383915 | None
Indicate the number of
outstanding shares of each of the issuer<U+0092>s classes of capital or common stock as of the close of the period covered by the annual report.
Ordinary Shares/Income Shares of <U+0080>0.34 each **
739,231,600
5% Cumulative Preference Shares of <U+... |
1 | 79383915_b0 | 79383915 |
8.
Listing of principal subsidiary undertakings and equity accounted investments.
12.
Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Public Company Accounting Reform and
Investor Protection Act of 2002.
13.
Certifications of Chief Executi... |
1 | 79383915_b1 | 79383915 | in this Annual Report on Form 20-F, which have been filed with the SEC at the SEC<U+0092>s public reference room located at 100 F Street, NW, Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public
reference rooms and their copy charges. The SEC filings are also available to ... |
1 | 79390340_0 | 79390340 | f20f_031814.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
View the table below in Excel
(Mark One)
[ ]
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934... |
1 | 79390340_1 | 79390340 | For the transition period from ________________ to ________________
OR
[ ]
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
Commission file number: 001-35990
PROSENSA... |
1 | 79390340_2 | 79390340 | Company Contact Person)
Copies to:
Richard D. Truesdell Jr.
Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017
Phone: (212) 450 4000
Fax: (212) 701 5800
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
... |
1 | 79390340_3 | 79390340 | covered by the annual report.
Common shares: 35,932,792
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
[ ] Yes [ x ] No
If this report is an annual or transition report, indicate by check mark if the registrant is not required t... |
1 | 79390340_b0 | 79390340 | performed the following services for the Company:
F - 42
View the table below in Excel
€ (‘000)
Year ended 31 December
2011
2012
2013
Audit fees ... |
1 | 79390340_b1 | 79390340 | were paid in total an amount of €34 thousand during the year ended December 31, 2013 and €50 thousand respectively during the years ended December 31, 2012 and 2011.
At the annual general meeting of shareholders on June 14, 2013 the shareholders approved, conditional upon the completion of the IPO, an individ... |
1 | 79392502_0 | 79392502 | Prepared by R.R. Donnelley Financial -- 10-K
Table of Contents
Index to Financial Statements
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For ... |
1 | 79392502_1 | 79392502 | incorporation or organization)
(I.R.S. Employer
Identification No.)
800 Chesapeake Drive
Redwood City, California
94063
(Address of principal executive offices)
(Zip Code)
(650) 995-8200
(Registrant<U+0092>s telephone number, including area code)
Securities registered pursuant to Sectio... |
1 | 79392502_2 | 79392502 | 13 or Section 15(d) of the Securities
Exchange Act. Yes ¨ No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was requir... |
1 | 79392502_3 | 79392502 | 92>s knowledge, in definitive proxy or information statements incorporated
by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See ... |
1 | 79392502_b0 | 79392502 |
X
101.DEF***
XBRL Taxonomy Extension Definition Linkbase Document
X
101.LAB***
XBRL Taxonomy Extension Labels Linkbase Document
X
101.PRE***
XBRL Taxonomy... |
1 | 79392502_b1 | 79392502 |
32.1**
Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350
X
101.INS***
XBRL Instance Document
... |
1 | 79392940_0 | 79392940 | Use these links to rapidly review the document TABLE OF CONTENTS1 TABLE OF CONTENT2 TABLE OF CONTENTS3
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
... |
1 | 79392940_1 | 79392940 | 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
o
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF... |
1 | 79392940_2 | 79392940 |
Campus Palmas Altas
C/ Energía Solar 1
41014, Seville, Spain
Tel: + 34 954 93 71 11
(Address of principal executive offices)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
Name of each exchange... |
1 | 79392940_3 | 79392940 | of capital or common stock as of the close of the period covered by the annual report:
741,116,971 Class B shares.
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities
Act. o Yes ý No
If this report is an annual or tra... |
1 | 79392940_b0 | 79392940 | 31,
2013
Year Ended
December 31,
2012
Year Ended
December 31,
2011
Parent only<U+0097>IFRS (loss) profit for the period
193,796
115,271
71,174
Additional profit/(loss) if subsidiaries had been accounted for using the equity method of accounting as opposed to cost method
... |
1 | 79392940_b1 | 79392940 | Investment in and advances to affiliates" at cost less any identified impairment loss.
b)
As
of December 31, 2013 and 2012 there were no material contingencies, significant provisions of long-term obligations, mandatory dividend or
redemption requirements of redeemable stocks or guarantees of the Company, excep... |
1 | 79401069_0 | 79401069 | UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 20-F
(Mark One)
View the table below in Excel
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PUR... |
1 | 79401069_1 | 79401069 | PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report________________________
For the transition period from__________ to ___________
Commission file number
001-36288
Celsus Therapeutics PLC(Exact name of R... |
1 | 79401069_2 | 79401069 | pursuant to Section 12(b) of the Act.
Title of each class
Name of each exchange on which registered
American Depositary Shares,
each representing 10 Ordinary Shares, par value £0.01 per share
Ordinary Shares, £0.01
par value p... |
1 | 79401069_3 | 79401069 | stock as of the close of the period covered by the annual report:
40,227,953 Ordinary Shares, £0.01 par value per share**
*
Not for trading, but only in connection with the registration
of American Depositary Shares representing such Ordinary Shares pursuant to the requirements of the Securities and Exchang... |
1 | 79401069_b0 | 79401069 |
(270
)
(440
)
(137
)
$
14
$
601
$
(128
)
NOTE 14:-
SUBSEQUENT
EVENTS
a.
On February 5, 2014, Celsus Therapeutics Plc (the “Company”) announced the closing
of its public o... |
1 | 79401069_b1 | 79401069 | -
Exchange rate
35
-
-
Other
7
6
9
284
1,041
9
Financial income:
Changes in values of deferred s... |
1 | 79402396_0 | 79402396 | Form 20-F
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 20<U+0096>F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH... |
1 | 79402396_1 | 79402396 |
Commission file number 001-35408
AVG
TECHNOLOGIES N.V. (Exact name of Registrant as specified in its charter
and translation of Registrant<U+0092>s name into English)
The Netherlands
(Jurisdiction of incorporation or organization)
Gatwickstraat 9-39, 1043 GL Amsterdam, The Netherlands
... |
1 | 79402396_2 | 79402396 | the number of outstanding shares of each of the issuer<U+0092>s classes of capital or common stock as of the close of the
period covered by the annual report.
Title of each class
Number of shares outstanding
Ordinary shares
53,150,630
Indicate by check mark if the registrant is a we... |
1 | 79402396_3 | 79402396 | 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past
90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitt... |
1 | 79402396_b0 | 79402396 |
Year Ended December 31,
2011
2012
2013
Class D preferred shares
12,000,000
<U+0097>
<U+0097>
Performance restricted stock units
<U+0097>
<U+0097>
26,630
Option... |
1 | 79402396_b1 | 79402396 |
Earnings per ordinary share<U+0097>basic
$
1.83
$
0.86
$
1.18
Earnings per ordinary share<U+0097>diluted
$
1.69
$
0.84
$
1.16
The following securities that could potentially dilute basic earnings per... |
1 | 79408931_0 | 79408931 | oxfd20140315_10k.htm
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
<U+2612>
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
OR
<U+26... |
1 | 79408931_1 | 79408931 |
England and Wales
Not Applicable
(State or Other Jurisdiction of
(I.R.S. Employer
Incorporation or Organization)
Identification No.)
View the table below in Excel
94C Innovation Drive, Milton Park, Abingdon OX14 4RZ, Uni... |
1 | 79408931_2 | 79408931 |
Title of each class
Name of exchange on which registered
Ordinary Shares, £0.006705 nominal value per share
The NASDAQ Global Market
Securities registered pursuant to Section 12(g) of the Act
None
Indicate by check mark if the registrant is a well-k... |
1 | 79408931_3 | 79408931 | filing requirements for the past 90 days. Yes <U+2612> No <U+2610>
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12... |
1 | 79408931_b0 | 79408931 |
1,450
108
193
Total
$
38,784
$
20,685
$
12,641
$
2,964
$
2,249
19. 2012 and 2013 acquisition activity
During November 2012 the Company entered into an agreement to acquire the assets of another corporation. As part of the process, in Decembe... |
1 | 79408931_b1 | 79408931 |
United Kingdom
2,795
2,466
1,800
360
314
Europe & ROW (excluding United Kingdom)
4,362
4,064
3,787
—
—
Europe & ROW
7,157
6,530
5,587
360
314
... |
1 | 79408978_0 | 79408978 | Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO FINANCIAL STATEMENTS
Table of Contents
As filed with the Securities and Exchange Commission on March 27, 2014
UNITED STATES
SECURITIE... |
1 | 79408978_1 | 79408978 | SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
o
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O... |
1 | 79408978_2 | 79408978 | ,
Address: Paul-Lenz Straße 1b, 86316 Friedberg, Germany(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities
registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
Name of each exchange o... |
1 | 79408978_3 | 79408978 |
Securities
registered for which there is a reporting obligation pursuant Section 15(d) of the Act.
None(Title of Class)
Indicate
the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period ... |
1 | 79408978_b0 | 79408978 | H was merged into VXLT 2013 AG upon registration of the merger in the commercial register of the surviving entity, VXLT
2013 AG. Concurrent with the effectiveness of the merger, VXLT 2013 AG changed its name to voxeljet AG.
In
connection with the merger, 1,950,000 ordinary shares of voxeljet AG were iss... |
1 | 79408978_b1 | 79408978 | of certain paintings which are placed in the administrative building in Friedberg. Associated rental expenses amount
to kEUR 2 in each of 2013, 2012 and 2011.
Further,
voxeljet acquired goods amounting to kEUR 20, kEUR 14, and kEUR 13 in 2013, 2012 and 2011 from 'Schlosserei und Metallbau Ederer', wh... |
1 | 79413339_0 | 79413339 | Form 20-F
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
þ
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC... |
1 | 79413339_1 | 79413339 | SEQUANS COMMUNICATIONS S.A.(Exact name of Registrant as specified in its charter)
Not Applicable (Translation of Registrant<U+0092>s name into English) French Republic
(Jurisdiction of incorporation or organization)
19 Le Parvis 92073 Paris-La Défense, France (Address of principal executive
offices) Georges... |
1 | 79413339_2 | 79413339 | value <U+0080>0.02 per
share Ordinary shares, nominal value <U+0080>0.02 per
share
New York Stock Exchange*
*
Not for trading, but only in connection with the registration of American Depositary Shares.
Securities registered or to be registered pursuant to Section 12(g) of the Act.
Not Applic... |
1 | 79413339_3 | 79413339 | Yes þ No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ¨ No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be fil... |
1 | 79413339_b0 | 79413339 | In addition to the warrants granted to Mr. Slonimsky as described above, the Company granted
warrants to certain members of the Board of Directors during the years ended December 31, 2011, 2012 and 2013: - On January 11,
2011, the Company granted to Messrs. Patterson, Sharma and Slonimsky 25,000 warrants each with... |
1 | 79413339_b1 | 79413339 | expense for key management personnel
$
5,251
$
4,660
$
4,005
Key management personnel comprises the chief executive officer and all executive vice presidents reporting directly to
him. The employment agreement ... |
1 | 79415888_0 | 79415888 | Use these links to rapidly review the document Table of Contents Index to Consolidated Financial Statements
Table of Contents
As filed with the Securities and Exchange Commission on March 31, 2014
UNITED STATE... |
1 | 79415888_1 | 79415888 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
o
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SE... |
1 | 79415888_2 | 79415888 | United States
Telephone No. 001 951 341 2375, E-Mail: dan.stracner@luxfer.net (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities
registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
Name of ea... |
1 | 79415888_3 | 79415888 | by the annual report: 13,407,288 Ordinary Shares of
£1 each and 769,413,708,000 Deferred Ordinary Shares of £0.0001 each.
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes o No ý
If this report is an annual or transition ... |
1 | 79415888_b0 | 79415888 | , the Gas Cylinders division made $7.6 million of sales to the joint venture. At December 31, 2013, the amounts receivable from the joint venture
amounted to $0.3 million of trade debt and $4.5 million of debt investment.
F-64
Table of Contents
LUXFER HOLDINGS PLC
NOTES TO THE CONSOLIDATED F... |
1 | 79415888_b1 | 79415888 | purchases one share (matching shares) which are
allocated to the employee. In the UK SIP, if the employee sells or transfers partnership shares within three years from the date of allocation, the linked matching shares are forfeited.
31. Related party transactions
Joint venture in which the Group is a ven... |
1 | 79427129_0 | 79427129 | f20f_040314.htm
As filed with the Securities and Exchange Commission on April 3, 2014
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
<U+25A1> REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934,
OR
ý ... |
1 | 79427129_1 | 79427129 | ACT OF 1934
Date of the event requiring this shell company report_________________________
000-29374
(Commission file number)
EDAP TMS S.A.
(Exact name of registrant as specified in its charter)
France
(Jurisdiction of incorporation or organization)
Parc d’Activites la Poudrette-Lamartine
... |
1 | 79427129_2 | 79427129 | (b) of the Act:
Title of each class
Name of each exchange on which registered
American Depositary Shares, each representing
NASDAQ Global Market
One Ordinary Share
Ordinary Shares, nominal value €0.13 per share
NASDAQ Global Market
Securities registered or to be registered pursuant to Section ... |
1 | 79427129_3 | 79427129 | the Securities Exchange Act of 1934. Yes ____ No X
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was require... |
1 | 79427129_b0 | 79427129 | refunds received)
118
143
143
Interest paid
293
401
38
Interest received
6
16
40
Non-cash transactions:
2013
2012
2011
Capital lease obli... |
1 | 79427129_b1 | 79427129 | and others
(693
)
(422
)
Balance as of December 31, 2013
1,094
737
F-47
EDAP TMS S.A. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands of euros unless otherwise noted, except per share data)
... |
1 | 79429579_0 | 79429579 | Use these links to rapidly review the document TABLE OF CONTENTS YANDEX N.V. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
... |
1 | 79429579_1 | 79429579 | OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
OR
o
SHELL COMPANY PURSUANT TO SECTION 13 OR 15(d... |
1 | 79429579_2 | 79429579 | Executive Officer
Schiphol Boulevard 165
Schiphol 1118 BG, The Netherlands
Telephone: +31 20-206-6970
Facsimile: +31 20-446-6372
Email: askIR@yandex-team.ru(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities
registered or t... |
1 | 79429579_3 | 79429579 | of the issuer's classes of capital or common stock as of the close of the period covered by the Annual Report.(1)
Title of each class
Number of shares outstanding
Class A
256,998,308
Class B
72,923,447
Indicate
by check mark if the registrant is a well-known seasone... |
1 | 79429579_b0 | 79429579 | including $4.0 (RUR 146 at the exchange rate as of the acquisition
date) paid in full upon closing of the deal, $3.9 (RUR 142 at the exchange rate as of the acquisition date) paid to escrow account that will be gradually released during four years after the
completion date to the KitLocate's founders subject to th... |
1 | 79429579_b1 | 79429579 | 31, 2013, the amount of receivables related to payment
processing was RUR 6 ($0.2). The Company believes that the terms of the agreements with Yandex.Money are comparable to the terms obtained in arm's-length transactions with unrelated similarly situated
customers and suppliers of the Company.
17. SUBSEQUE... |
1 | 79434197_0 | 79434197 | 20-F
Table of Contents
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ... |
1 | 79434197_1 | 79434197 | Biotech plc (Exact name of Registrant as specified in its charter and translation of Registrant<U+0092>s name into English)
Ireland (Jurisdiction of
incorporation or organization) IDA Business Park, Bray, Co. Wicklow, Ireland
(Address of principal executive offices)
Kevin Tansley Chief
Financial Offi... |
1 | 79434197_2 | 79434197 | , par value US$0.0109)
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuer<U+0092>s classes of capital or common stock as of the close of the period covered
by the annual report: 92,296,506 Class <U+... |
1 | 79434197_3 | 79434197 | change Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨ Indicate by check mark
whether the registrant has submitted electronically and posted on its cor... |
1 | 79434197_b0 | 79434197 | Kevin Tansley
Company secretary/
Chief Financial Officer
Date: April 9, 2014
130
Table of Contents
Item 19
Exhibits
View the table below in Excel
Exhibit No.
Description of Exhibit
4.1
Agreement and Plan of ... |
1 | 79434197_b1 | 79434197 | atures The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorised the undersigned to sign this Annual Report on its behalf.
View the table below in Excel
TRINITY BIOTECH PLC
By:
/s/ ... |
1 | 79436824_0 | 79436824 | 20-F
Table of Contents
SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549
FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 193... |
1 | 79436824_1 | 79436824 |
CGG
(Exact name of registrant as specified in its charter)
CGG
(Translation of registrant<U+0092>s name into English)
Republic of France (Jurisdiction of incorporation or organization) Tour Maine
Montparnasse 33, avenue du Maine 75015 Paris France (Address of principal executive
offices) Stephan... |
1 | 79436824_2 | 79436824 | per share
New York Stock Exchange
Securities registered or to be registered pursuant to Section 12(g) of the Act.
None
(Title of class) Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. 7 3/4% Senior Notes due 2017
9 1/2% Senior Notes due 2016
6 1/2% Senior Note... |
1 | 79436824_3 | 79436824 | (d) of the Securities Exchange Act of
1934. Yes ¨ No x Note <U+0097> checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those
sections. Indicate by check mark whether the registran... |
1 | 79436824_b0 | 79436824 |
<U+0097>
(6.9
)
(6.9
)
Cash at opening
282.3
15.9
21.6
129.0
<U+0097>
... |
1 | 79436824_b1 | 79436824 |
(438.7
)
(7.0
)
(36.7
)
446.8
(538.5
)
Cash flow from financing activities
(456.3
)
(8.1
)
(116.2
)
47.5
371.2
(161.9
)
Effect of exchange rates on cash
<U+0097>
... |
1 | 79458003_0 | 79458003 | Use these links to rapidly review the document TABLE OF CONTENTS UNIQURE N.V. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Table of Contents
SECURITIES AND EXCHANGE COMMISSIONWashington D.C. 20549
FORM 20-F ... |
1 | 79458003_1 | 79458003 | EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period
from to
o
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR... |
1 | 79458003_2 | 79458003 | +31 20 566 7394
Fax: +31 20 566 9272
Meibergdreef 61, 1105BA Amsterdam, The Netherlands(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities
registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
Name o... |
1 | 79458003_3 | 79458003 | 31, 2013)
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
o Yes ý No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of t... |
1 | 79458003_b0 | 79458003 | for the delivery of AAV vectors to CNS or liver cells for the diagnosis, treatment,
palliation or prevention of all diseases or medical conditions. Under this collaboration, the 4D team, including Dr. David Schaffer, 4D's co-founder and Professor of Chemical and Biomolecular
Engineering at the University of Califo... |
1 | 79458003_b1 | 79458003 | in the second quarter of 2013. The Company's engagement letter with Extera Partners
contains a cap limiting the maximum payment to €5.0 million. On December 23, 2013 proceedings under the International Court of Arbitration formally
F-54
Table of Contents
commenced.
The Company has reviewed this ... |
1 | 79469251_0 | 79469251 | Form 20-F
Table of Contents
Natuzzi S.p.A
Annual Report on Form 20-F 2013
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 ... |
1 | 79469251_1 | 79469251 | 80 8820 812; pdirenzo@natuzzi.com; Via Iazzitiello 47, 70029 Santeramo in Colle, Bari, Italy
(Name, telephone, e-mail and/or facsimile number and address of company contact person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each ... |
1 | 79469251_2 | 79469251 | of the close of the period covered by the annual
report: As of December 31, 2013 54,853,045 Ordinary Shares
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined
in Rule 405 of the Securities Act. Yes ¨ No x
If this report is an annual or transition report, indicate by ch... |
1 | 79469251_3 | 79469251 | be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨ Indicate by check mark whether the registrant is a large accelerated filer, an ac... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.